Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin.

Antimicrobial Agents and Chemotherapy
Joanna A MajchrzykiewiczJetta J E Bijlsma

Abstract

To investigate the response of Streptococcus pneumoniae to three distinct antimicrobial peptides (AMPs), bacitracin, nisin, and LL-37, transcriptome analysis of challenged bacteria was performed. Only a limited number of genes were found to be up- or downregulated in all cases. Several of these common highly induced genes were chosen for further analysis, i.e., SP0385-SP0387 (SP0385-0387 herein), SP0912-0913, SP0785-0787, SP1714-1715, and the blp gene cluster. Deletion of these genes in combination with MIC determinations showed that several putative transporters, i.e., SP0785-0787 and SP0912-0913, were indeed involved in resistance to lincomycin and LL-37 and to bacitracin, nisin, and lincomycin, respectively. Mutation of the blp bacteriocin immunity genes resulted in an increased sensitivity to LL-37. Interestingly, a putative ABC transporter (SP1715) protected against bacitracin and Hoechst 33342 but conferred sensitivity to LL-37. A GntR-like regulator, SP1714, was identified as a negative regulator of itself and two of the putative transporters. In conclusion, we show that resistance to three different AMPs in S. pneumoniae is mediated by several putative ABC transporters, some of which have not been associated with antimi...Continue Reading

References

Dec 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·K J Stone, J L Strominger
Sep 8, 1971·Journal of the American Chemical Society·E Gross, J L Morell
Feb 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·F N ChangB Weisblum
Feb 1, 1981·Applied and Environmental Microbiology·M K RaymanA Hurst
Jan 1, 1995·Methods in Molecular Biology·H Holo, I F Nes
Jul 1, 1993·Applied Biochemistry and Biotechnology·E C AzevedoG M Campos-Takaki
Oct 1, 1996·Applied and Environmental Microbiology·P G de RuyterW M de Vos
Nov 27, 1996·Molecular & General Genetics : MGG·K LeenhoutsJ Kok
Sep 16, 1998·Antimicrobial Agents and Chemotherapy·J TurnerR I Lehrer
Dec 11, 1999·Biochimica Et Biophysica Acta·E Breukink, B de Kruijff
Feb 15, 2000·Molecular Microbiology·J P ThroupM K Burnham
Sep 7, 2001·Journal of Bacteriology·N KobayashiA Yamaguchi
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Hiromasa TsudaToshihiko Koga
Dec 18, 2002·Journal of Bacteriology·Thorsten MascherRegine Hakenbeck
Feb 1, 2003·Drugs·Andreas R Koczulla, Robert Bals
Aug 13, 2003·Bioinformatics·Sacha A F T van HijumOscar P Kuipers
Nov 13, 2003·FEMS Microbiology Letters·Remi BernardFrançois Denizot
Dec 4, 2003·Molecular Microbiology·Thorsten MascherJohn D Helmann
Mar 24, 2004·Nature Reviews. Microbiology·Timothy J Mitchell
May 25, 2004·Infection and Immunity·Yasser Musa IbrahimTim J Mitchell
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Thorsten MascherJohn D Helmann
Sep 24, 2004·Infection and Immunity·Carlos J OrihuelaElaine I Tuomanen
Jan 11, 2005·Applied and Environmental Microbiology·Glen S TamuraAphakorn Nittayajarn
Jun 29, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary V DoernSusan Beekmann
Nov 18, 2005·Journal of Bacteriology·Wolfgang HaasElaine I Tuomanen

❮ Previous
Next ❯

Citations

Sep 21, 2011·The Journal of Antimicrobial Chemotherapy·Tina Wecke, Thorsten Mascher
Jul 6, 2012·Proceedings. Biological Sciences·Michelle G J L HabetsMichael A Brockhurst
May 26, 2010·Antimicrobial Agents and Chemotherapy·Dorothea ZähnerDavid S Stephens
Nov 25, 2014·Antibiotics·Kathryn L NawrockiShonna M McBride
Mar 1, 2016·Nature Communications·Colin C KietzmanElaine I Tuomanen
Feb 4, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Lucía FernándezRobert E W Hancock
Feb 24, 2015·Biochimica Et Biophysica Acta·Christopher N LaRock, Victor Nizet
Dec 19, 2012·Cellular Immunology·Dieter VandammeLiliane Schoofs
Oct 6, 2015·BioFactors·Katarzyna BandurskaPiotr Krupa
Jul 29, 2016·Microbiology and Molecular Biology Reviews : MMBR·Konstantinos PapadimitriouJan Kok
Mar 20, 2015·Microbiology and Molecular Biology Reviews : MMBR·Lorraine A DraperR Paul Ross
Oct 26, 2018·Medicinal Research Reviews·Jiajun WangAnshan Shan
Jan 18, 2018·Nature Communications·Hong-Bo YangCong-Zhao Zhou
Mar 3, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Piyush BaindaraSanti M Mandal
Dec 6, 2017·Cell and Tissue Research·Megan L Lewis, Bas G J Surewaard
Feb 20, 2019·Frontiers in Chemistry·Evan F HaneyRobert E W Hancock
Jul 15, 2018·Antonie van Leeuwenhoek·Luz E Casados-VázquezJosé E Barboza-Corona
Jan 7, 2017·World Journal of Microbiology & Biotechnology·Eirini-Evangelia ThomloudiMaria Dimou
Jun 13, 2018·Frontiers in Microbiology·Nicholas P GreeneVassilis Koronakis
Jan 28, 2021·Molecular Biology and Evolution·Angharad E GreenDaniel R Neill
Nov 17, 2020·Frontiers in Microbiology·Lucas AssoniMichelle Darrieux
Mar 19, 2020·Microorganisms·Pierre-Alexander MückeDörte Becher
Mar 23, 2021·Frontiers in Bioengineering and Biotechnology·Lieke A van GijtenbeekGunnar Oregaard
Mar 22, 2016·Microbiology Spectrum·Jason N Cole, Victor Nizet
Jun 30, 2021·Nature Reviews. Microbiology·Robert E W HancockEvan F Haney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

ABC Transporters & Multidrug Resistance

ABC Transporters or ATP-Binding Cassette Transporters are responsible for pumping out antibiotics in the cell and can lead to multidrug resistance in bacteria. Discover the latest research on ABC Transporters & Multidrug Resistance here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.